Cognition Therapeutics, Inc. (CGTX) Reports In-Line Q2 EPS

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11).

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• DoorDash Inc. (DASH) PT Lowered to $270 at Benchmark
• Oiln (OLN) PT Lowered to $20 at RBC Capital on Price Weakness in 2H
• Nextpower (NXT) PT Lowered to $160 at UBS